Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

88 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tezacaftor/Ivacaftor in Subjects with Cystic Fibrosis and F508del/F508del-CFTR or F508del/G551D-CFTR.
Donaldson SH, Pilewski JM, Griese M, Cooke J, Viswanathan L, Tullis E, Davies JC, Lekstrom-Himes JA, Wang LT; VX11-661-101 Study Group. Donaldson SH, et al. Among authors: viswanathan l. Am J Respir Crit Care Med. 2018 Jan 15;197(2):214-224. doi: 10.1164/rccm.201704-0717OC. Am J Respir Crit Care Med. 2018. PMID: 28930490 Free PMC article. Clinical Trial.
Safety and efficacy of vanzacaftor-tezacaftor-deutivacaftor in adults with cystic fibrosis: randomised, double-blind, controlled, phase 2 trials.
Uluer AZ, MacGregor G, Azevedo P, Indihar V, Keating C, Mall MA, McKone EF, Ramsey BW, Rowe SM, Rubenstein RC, Taylor-Cousar JL, Tullis E, Yonker LM, Chu C, Lam AP, Nair N, Sosnay PR, Tian S, Van Goor F, Viswanathan L, Waltz D, Wang LT, Xi Y, Billings J, Horsley A; VX18-121-101; VX18-561-101 Study Groups. Uluer AZ, et al. Among authors: viswanathan l. Lancet Respir Med. 2023 Jun;11(6):550-562. doi: 10.1016/S2213-2600(22)00504-5. Epub 2023 Feb 23. Lancet Respir Med. 2023. PMID: 36842446 Free article. Clinical Trial.
Phase 1 Study to Assess the Safety and Pharmacokinetics of Elexacaftor/Tezacaftor/Ivacaftor in Subjects Without Cystic Fibrosis With Moderate Hepatic Impairment.
Viswanathan L, Bachman E, Tian S, Ahluwalia N, Zhang Y, Bernstein HS, Panorchan P. Viswanathan L, et al. Eur J Drug Metab Pharmacokinet. 2022 Nov;47(6):817-825. doi: 10.1007/s13318-022-00791-8. Epub 2022 Aug 29. Eur J Drug Metab Pharmacokinet. 2022. PMID: 36036885 Free PMC article. Clinical Trial.
Diffuse Meningeal Melanomatosis with Congenital Facial Nevus in an Adult.
Viswanathan LG, Seshagiri DV, Rao S, Neerupaka V, Kulanthaivelu K, Nagappa M, Sinha S. Viswanathan LG, et al. Ann Indian Acad Neurol. 2023 Nov-Dec;26(6):1006-1007. doi: 10.4103/aian.aian_579_23. Epub 2023 Oct 5. Ann Indian Acad Neurol. 2023. PMID: 38229622 Free PMC article. No abstract available.
Localisation of eloquent cortex using magnetoencephalography and its clinical implications.
Mishra R, Mariyappa N, Rao Malla B, Arivazhagan A, Mishra B, Gautham B, Chowdary Mundlamuri R, Jayabal V, Raghavendra K, Asranna A, Viswanathan LG, Sadashiva N, Bharath RD, Saini J, Nagaraj C, Mangalore S, Karthik K, Rajeswaran J, Kumar K, Mahadevan A, Sinha S. Mishra R, et al. Among authors: viswanathan lg. Int J Neurosci. 2023 Oct 12:1-13. doi: 10.1080/00207454.2023.2270684. Online ahead of print. Int J Neurosci. 2023. PMID: 37824719
88 results